Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare...
Read moreThe annual Vancouver Resource Investment Conference (VRIC) took place at the Vancouver Convention Center from January 19 to 20, bringing...
Read moreRio Silver Inc. (TSXV:RYO) (‘Rio Silver’) and African Energy Metals Inc. (NEX: CUCO.H; FSE: BC2; WKN: A3DEJG) (‘African Energy Metals’)...
Read moreOversupply and shifting battery chemistries are set to define the cobalt market in 2025. Prices -subdued by excess supply since...
Read moreEuropean Lithium Limited (ASX: EUR, FRA: PF8, OTC: EULIF) (European Lithium or the Company) is pleased to announce Critical Metals...
Read moreFirst Helium Inc. (‘First Helium’ or the ‘Company’) (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) today announced that it has begun...
Read moreExplorer Amarc Resources (TSXV:AHR,OTCQB:AXREF) experienced a sharp increase in its share price following the announcement of a new discovery at...
Read moreThere’s been a great deal of speculation surrounding a potential Starlink initial public offering (IPO), and the idea of an...
Read moreAs the energy transition continues to unfold, US electric vehicle (EV) pioneer Tesla (NASDAQ:TSLA) has been making moves to secure...
Read moreCanadian oil and gas stocks have faced a rollercoaster ride over the past few years. However, analysts remain optimistic about...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved